Paolo Angeli
Università degli Studi di Padova
H-index: 98
Europe-Italy
Top articles of Paolo Angeli
Acute kidney injury in patients with Cirrhosis: Acute disease quality Initiative (ADQI) and international Club of ascites (ICA) joint multidisciplinary consensus meeting
2024/3/26
Profiling plasma alterations of extracellular vesicles in patients with acutely decompensated cirrhosis and bacterial infection
Liver International
2024/3/22
Elena Campello
H-Index: 20
Paolo Angeli
H-Index: 57
Acute and non‐acute decompensation of liver cirrhosis (47/130)
2024/3/1
Paolo Angeli
H-Index: 57
Jonel Trebicka
H-Index: 50
Democracy in Science
Journal of Hepatology
2024/2/14
Paolo Angeli
H-Index: 57
Validating and expanding Baveno VII criteria of recompensation in patients with decompensated cirrhosis
Digestive and Liver Disease
2024/2/1
Liver Frailty Index predicts poor outcomes in patients hospitalized for acute decompensation of cirrhosis
Digestive and Liver Disease
2024/2/1
Real-life experience of long-term albumin treatment for the management of ascites in patients with decompensated cirrhosis accross Italy
Digestive and Liver Disease
2024/2/1
Changes in mean arterial pressure are inadequate to guide treatment with terlipressin and albumin in patients with hepatorenal syndrome-acute kidney injury
Digestive and Liver Disease
2024/2/1
Mild overt hepatic encephalopathy (HE)-more than meets the eye
Digestive and Liver Disease
2024/2/1
1-Piperidine propionic acid is effective in reducing HCC development and fatty acid accumulation in experimental liver carcinogenesis
Digestive and Liver Disease
2024/2/1
Looking for a deeper characterization of new decompensation patterns
Journal of Hepatology
2024/5/2
Marta Tonon
H-Index: 10
Paolo Angeli
H-Index: 57
Long-term albumin administration improves survival in outpatients with decompensated cirrhosis and diabetes: post-hoc analysis of the ANSWER Trial
Journal of Hepatology
2017
Predictors of clinical trajectories in patients surviving an acute decompensation of cirrhosis
Digestive and Liver Disease
2024/2/1
Determinants of clinical response to empirical antibiotic treatment in patients with cirrhosis and bacterial and fungal infections—Results from the ICA “Global Study”(EABCIR …
Hepatology
2024/5/1
Serum ammonia predicts mortality in patients with hepatocellular carcinoma
Digestive and Liver Disease
2024/2/1
Infectious Complications of Portal Hypertension
Clinics in Liver Disease
2024/4/27
Paolo Angeli
H-Index: 57
Salvatore Piano
H-Index: 30
Experimental Investigation of a Device to Restrain the Horizontal Sliding of U-FREIs
Applied Sciences
2024/4/17
Paolo Angeli
H-Index: 57
OP-4 DEVELOPMENT AND EXTERNAL VALIDATION OF A MODEL TO PREDICT MULTI-DRUG RESISTANT BACTERIAL INFECTIONS IN PATIENTS WITH CIRRHOSIS
Annals of Hepatology
2024/2/1
Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL-a randomised clinical biomarker validation trial
BMJ open
2024/2/1
The polymorphic variant of SerpinB3 (SerpinB3‐PD) is associated with faster cirrhosis decompensation
Alimentary Pharmacology & Therapeutics
2024/2
